HPSE and type 1 diabetes mellitus: This suggests that therapies that focus on strengthening the basement membrane of the islets (e.g. heparanase inhibition [57, 58]) has the potential to lead to a smaller population of T cells in the pancreatic tissue, which can be exploited for T1D treatment.